Esterification of plasma membrane cholesterol and triacylglycerol-rich lipoprotein secretion in CaCo-2 cells: possible role of p-glycoprotein
- PMID: 7595077
Esterification of plasma membrane cholesterol and triacylglycerol-rich lipoprotein secretion in CaCo-2 cells: possible role of p-glycoprotein
Abstract
Acylcoenzyme A:cholesterol acyltransferase (ACAT) and/or cholesteryl esters have been implicated as important factors in the normal assembly of apolipoprotein (apoB)-containing lipoproteins. The predominant substrate for ACAT is believed to originate from cholesterol contained within the plasma membrane. To investigate a possible role of intestinal plasma membrane cholesterol in triacylglycerol-rich lipoprotein synthesis and secretion, CaCo-2 cells were incubated with agents that are known to interfere with cholesterol transport from the plasma membrane to the ER. Progesterone, verapamil, and trifluoperazine significantly decreased the movement of cholesterol from plasma membrane to endoplasmic reticulum (ER) in CaCo-2 cells. Without altering the synthesis of apoB and independent of their effects on cellular cholesterol esterification, progesterone, verapamil, and trifluoperazine decreased the basolateral secretion of triacylglycerols, cholesteryl esters, and immunoreactive and newly synthesized apoB. The three agents also interfered with the esterification of cholesterol absorbed from taurocholate micelles. As progesterone, verapamil, and trifluoperazine are recognized inhibitors of p-glycoprotein, a variety of agents that have been shown to interfere with p-glycoprotein function were tested to investigate their effects on cholesterol transport and apoB secretion. All the agents significantly decreased in parallel both cholesterol transport and apoB secretion. In contrast, methotrexate, an antimetabolite that does not interact with p-glycoprotein, had no effect. Nigericin, a potassium ionophore, which causes alkalinization of intracellular vesicles, also caused a profound inhibition of cholesterol transport and apoB secretion. Preventing plasma membrane cholesterol from arriving at the ER, or inhibiting the esterification of plasma membrane cholesterol, does not alter apoB secretion. However, the results suggest a possible role for p-glycoprotein in normal cholesterol trafficking and triacylglycerol-rich lipoprotein secretion in CaCo-2 cells. It is postulated that p-glycoprotein might function to maintain the acidic environment of transport vesicles, and therefore, could play a role in the transport of lipids by the intestine.
Similar articles
-
Triacylglycerol-rich lipoprotein cholesterol is derived from the plasma membrane in CaCo-2 cells.J Lipid Res. 1995 Dec;36(12):2651-60. J Lipid Res. 1995. PMID: 8847491
-
Apple procyanidins decrease cholesterol esterification and lipoprotein secretion in Caco-2/TC7 enterocytes.J Lipid Res. 2005 Feb;46(2):258-68. doi: 10.1194/jlr.M400209-JLR200. Epub 2004 Dec 1. J Lipid Res. 2005. PMID: 15576849
-
Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells.Biochim Biophys Acta. 1996 Jul 12;1302(1):46-54. doi: 10.1016/0005-2760(96)00030-6. Biochim Biophys Acta. 1996. PMID: 8695654
-
Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion.Clin Chim Acta. 1999 Aug;286(1-2):231-42. doi: 10.1016/s0009-8981(99)00104-7. Clin Chim Acta. 1999. PMID: 10511295 Review.
-
The molecular mechanism for the assembly and secretion of ApoB-100-containing lipoproteins.Prog Lipid Res. 1991;30(2-3):205-18. doi: 10.1016/0163-7827(91)90017-y. Prog Lipid Res. 1991. PMID: 1823939 Review.
Cited by
-
The effects of pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells.Pharm Res. 2003 Jul;20(7):1085-92. doi: 10.1023/a:1024422625596. Pharm Res. 2003. PMID: 12880295
-
Evaluation of the contribution of the ATP binding cassette transporter, P-glycoprotein, to in vivo cholesterol homeostasis.Mol Pharm. 2013 Aug 5;10(8):3203-12. doi: 10.1021/mp4002415. Epub 2013 Jun 24. Mol Pharm. 2013. PMID: 23750858 Free PMC article.
-
Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies.J Bioenerg Biomembr. 1997 Aug;29(4):401-13. doi: 10.1023/a:1022459100409. J Bioenerg Biomembr. 1997. PMID: 9387101 Review.
-
Dose-dependent targeted suppression of P-glycoprotein expression and function in Caco-2 cells.Mol Pharm. 2013 Jun 3;10(6):2323-30. doi: 10.1021/mp300668e. Epub 2013 May 2. Mol Pharm. 2013. PMID: 23611024 Free PMC article.
-
Lipid rafts: dream or reality for cholesterol transporters?Eur Biophys J. 2007 Nov;36(8):869-85. doi: 10.1007/s00249-007-0193-8. Epub 2007 Jun 19. Eur Biophys J. 2007. PMID: 17576551 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous